BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 26971899)

  • 21. The specificity of acute and chronic microvascular alterations in renal allografts.
    Filippone EJ; Farber JL
    Clin Transplant; 2013; 27(6):790-8. PubMed ID: 24118527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.
    Niikura T; Yamamoto I; Nakada Y; Kamejima S; Katsumata H; Yamakawa T; Furuya M; Mafune A; Kobayashi A; Tanno Y; Miki J; Yamada H; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():75-8. PubMed ID: 26031592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological analysis of late renal allografts of antidonor antibody positive patients with C4d deposits in peritubular capillaries.
    Aita K; Yamaguchi Y; Shimizu T; Horita S; Furusawa M; Tanabe K; Fuchinoue S; Toma H
    Clin Transplant; 2004; 18 Suppl 11():7-12. PubMed ID: 15191366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Complement-binding Donor-specific Antibodies, Not IgG-antibody Strength Nor C4d Status, at Antibody-mediated Rejection Diagnosis Is an Independent Predictor of Kidney Graft Failure.
    Malheiro J; Santos S; Tafulo S; Dias L; Martins S; Fonseca I; Almeida M; Pedroso S; Beirão I; Castro-Henriques A; Cabrita A
    Transplantation; 2018 Nov; 102(11):1943-1954. PubMed ID: 29757900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.
    Hayde N; Bao Y; Pullman J; Ye B; Calder RB; Chung M; Schwartz D; Lubetzky M; Ajaimy M; de Boccardo G; Akalin E
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2141-8. PubMed ID: 24030736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Banff 2013 update: Pearls and pitfalls in transplant renal pathology.
    Hara S
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():2-8. PubMed ID: 26031578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of antibody mediated rejection shortly after acute cellular rejection in a pediatric kidney transplantation recipient.
    Okada M; Kamei K; Matsuoka K; Ito S
    CEN Case Rep; 2018 Nov; 7(2):288-291. PubMed ID: 29949115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C4d deposition in peritubular capillary and alloantibody in the allografted kidney suffering severe acute rejection.
    Abe M; Sawada T; Horita S; Toma H; Yamaguchi Y; Teraoka S
    Clin Transplant; 2003; 17 Suppl 10():14-9. PubMed ID: 12823251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute T cell-mediated rejection accompanied by C4d-negative acute antibody-mediated rejection and cell debris in tubulus: A case report.
    Takamura T; Yamamoto I; Nakada Y; Katsumata H; Yamakawa T; Furuya M; Mafune A; Kobayashi A; Tanno Y; Miki J; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():70-4. PubMed ID: 26031591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.
    Orandi BJ; Alachkar N; Kraus ES; Naqvi F; Lonze BE; Lees L; Van Arendonk KJ; Wickliffe C; Bagnasco SM; Zachary AA; Segev DL; Montgomery RA
    Am J Transplant; 2016 Jan; 16(1):213-20. PubMed ID: 26317487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of acute antibody-mediated rejection using bortezomib: a case report.
    Sin YH; Kim YJ; Oh JS; Lee JH; Kim SM; Kim JK
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():86-9. PubMed ID: 26031595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refinement of the criteria for ultrastructural peritubular capillary basement membrane multilayering in the diagnosis of chronic active/acute antibody-mediated rejection.
    Go H; Shin S; Kim YH; Han DJ; Cho YM
    Transpl Int; 2017 Apr; 30(4):398-409. PubMed ID: 28109026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond C4d: the ultrastructural appearances of endothelium in ABO-incompatible renal allografts.
    Bröcker V; Pfaffenbach A; Habicht A; Chatzikyrkou C; Kreipe HH; Haller H; Scheffner I; Gwinner W; Zilian E; Immenschuh S; Schwarz A; Horn PA; Heinemann FM; Becker JU
    Nephrol Dial Transplant; 2013 Dec; 28(12):3101-9. PubMed ID: 24081856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of Prolonged Treatment With Intravenous Immunoglobulin Infusions for Acute Antibody-mediated Rejection in Kidney Transplant Recipients.
    Bujnowska A; Michon M; Konopelski P; Hryniewiecka E; Jalbrzykowska A; Perkowska-Ptasinska A; Cieciura T; Zagozdzon R; Paczek L; Ciszek M
    Transplant Proc; 2018; 50(6):1720-1725. PubMed ID: 29961551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of C4d staining as a humoral injury marker.
    Kara M; Demir F; Ata P; Ozel L; Gumrukcu G; Unal E; Canbakan M; Gucun M; Esadoglu V; Ozdemir E; Cemel H; Titiz MI
    Transplant Proc; 2012; 44(6):1694-6. PubMed ID: 22841245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early humoral-mediated graft injuries in ABO-incompatible kidney transplantation in human beings.
    Sekijima M; Shimizu A; Ishii Y; Kudo S; Horita S; Nakajima I; Fuchinoue S; Teraoka S
    Transplant Proc; 2010 Apr; 42(3):789-90. PubMed ID: 20430172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries.
    Collins AB; Schneeberger EE; Pascual MA; Saidman SL; Williams WW; Tolkoff-Rubin N; Cosimi AB; Colvin RB
    J Am Soc Nephrol; 1999 Oct; 10(10):2208-14. PubMed ID: 10505698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunohistochemical expression of von Willebrand factor, T-cadherin, and Caveolin-1 is increased in kidney allograft biopsies with antibody-mediated injury.
    Teixeira AC; Távora F; de Deus E Silva MLF; Prado RMG; de Matos Esmeraldo R; de Sandes-Freitas TV
    Clin Exp Nephrol; 2021 Mar; 25(3):305-314. PubMed ID: 33242156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts.
    Haas M; Segev DL; Racusen LC; Bagnasco SM; Locke JE; Warren DS; Simpkins CE; Lepley D; King KE; Kraus ES; Montgomery RA
    J Am Soc Nephrol; 2009 Jan; 20(1):197-204. PubMed ID: 18776120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subclinical antibody-mediated rejection due to anti-human-leukocyte-antigen-DR53 antibody accompanied by plasma cell-rich acute rejection in a patient with cadaveric kidney transplantation.
    Katsuma A; Yamamoto I; Komatsuzaki Y; Niikura T; Kawabe M; Okabayashi Y; Yamakawa T; Katsumata H; Nakada Y; Kobayashi A; Tanno Y; Miki J; Yamada H; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():31-4. PubMed ID: 26971538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.